Company Overview
LISATA THERAPEUTICS, INC.
LSTARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
1M
2024 FY
Net Income
-20M
2024 FY
Shares Outstanding
8M
2024 FY
EPS
-2.4USD
2024 FY
Company Information
SIC Code
2834
CIK Code
320017
Exchange
Nasdaq
Location
US